Cargando…

Moving on From Representativeness: Testing the Utility of the Global Drug Survey

A decline in response rates in traditional household surveys, combined with increased internet coverage and decreased research budgets, has resulted in increased attractiveness of web survey research designs based on purposive and voluntary opt-in sampling strategies. In the study of hidden or stigm...

Descripción completa

Detalles Bibliográficos
Autores principales: Barratt, Monica J, Ferris, Jason A, Zahnow, Renee, Palamar, Joseph J, Maier, Larissa J, Winstock, Adam R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5595253/
https://www.ncbi.nlm.nih.gov/pubmed/28924351
http://dx.doi.org/10.1177/1178221817716391
_version_ 1783263335797489664
author Barratt, Monica J
Ferris, Jason A
Zahnow, Renee
Palamar, Joseph J
Maier, Larissa J
Winstock, Adam R
author_facet Barratt, Monica J
Ferris, Jason A
Zahnow, Renee
Palamar, Joseph J
Maier, Larissa J
Winstock, Adam R
author_sort Barratt, Monica J
collection PubMed
description A decline in response rates in traditional household surveys, combined with increased internet coverage and decreased research budgets, has resulted in increased attractiveness of web survey research designs based on purposive and voluntary opt-in sampling strategies. In the study of hidden or stigmatised behaviours, such as cannabis use, web survey methods are increasingly common. However, opt-in web surveys are often heavily criticised due to their lack of sampling frame and unknown representativeness. In this article, we outline the current state of the debate about the relevance of pursuing representativeness, the state of probability sampling methods, and the utility of non-probability, web survey methods especially for accessing hidden or minority populations. Our article has two aims: (1) to present a comprehensive description of the methodology we use at Global Drug Survey (GDS), an annual cross-sectional web survey and (2) to compare the age and sex distributions of cannabis users who voluntarily completed (a) a household survey or (b) a large web-based purposive survey (GDS), across three countries: Australia, the United States, and Switzerland. We find that within each set of country comparisons, the demographic distributions among recent cannabis users are broadly similar, demonstrating that the age and sex distributions of those who volunteer to be surveyed are not vastly different between these non-probability and probability methods. We conclude that opt-in web surveys of hard-to-reach populations are an efficient way of gaining in-depth understanding of stigmatised behaviours and are appropriate, as long as they are not used to estimate drug use prevalence of the general population.
format Online
Article
Text
id pubmed-5595253
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-55952532017-09-18 Moving on From Representativeness: Testing the Utility of the Global Drug Survey Barratt, Monica J Ferris, Jason A Zahnow, Renee Palamar, Joseph J Maier, Larissa J Winstock, Adam R Subst Abuse Original Research A decline in response rates in traditional household surveys, combined with increased internet coverage and decreased research budgets, has resulted in increased attractiveness of web survey research designs based on purposive and voluntary opt-in sampling strategies. In the study of hidden or stigmatised behaviours, such as cannabis use, web survey methods are increasingly common. However, opt-in web surveys are often heavily criticised due to their lack of sampling frame and unknown representativeness. In this article, we outline the current state of the debate about the relevance of pursuing representativeness, the state of probability sampling methods, and the utility of non-probability, web survey methods especially for accessing hidden or minority populations. Our article has two aims: (1) to present a comprehensive description of the methodology we use at Global Drug Survey (GDS), an annual cross-sectional web survey and (2) to compare the age and sex distributions of cannabis users who voluntarily completed (a) a household survey or (b) a large web-based purposive survey (GDS), across three countries: Australia, the United States, and Switzerland. We find that within each set of country comparisons, the demographic distributions among recent cannabis users are broadly similar, demonstrating that the age and sex distributions of those who volunteer to be surveyed are not vastly different between these non-probability and probability methods. We conclude that opt-in web surveys of hard-to-reach populations are an efficient way of gaining in-depth understanding of stigmatised behaviours and are appropriate, as long as they are not used to estimate drug use prevalence of the general population. SAGE Publications 2017-06-30 /pmc/articles/PMC5595253/ /pubmed/28924351 http://dx.doi.org/10.1177/1178221817716391 Text en © The Author(s) 2017 http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page(https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Research
Barratt, Monica J
Ferris, Jason A
Zahnow, Renee
Palamar, Joseph J
Maier, Larissa J
Winstock, Adam R
Moving on From Representativeness: Testing the Utility of the Global Drug Survey
title Moving on From Representativeness: Testing the Utility of the Global Drug Survey
title_full Moving on From Representativeness: Testing the Utility of the Global Drug Survey
title_fullStr Moving on From Representativeness: Testing the Utility of the Global Drug Survey
title_full_unstemmed Moving on From Representativeness: Testing the Utility of the Global Drug Survey
title_short Moving on From Representativeness: Testing the Utility of the Global Drug Survey
title_sort moving on from representativeness: testing the utility of the global drug survey
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5595253/
https://www.ncbi.nlm.nih.gov/pubmed/28924351
http://dx.doi.org/10.1177/1178221817716391
work_keys_str_mv AT barrattmonicaj movingonfromrepresentativenesstestingtheutilityoftheglobaldrugsurvey
AT ferrisjasona movingonfromrepresentativenesstestingtheutilityoftheglobaldrugsurvey
AT zahnowrenee movingonfromrepresentativenesstestingtheutilityoftheglobaldrugsurvey
AT palamarjosephj movingonfromrepresentativenesstestingtheutilityoftheglobaldrugsurvey
AT maierlarissaj movingonfromrepresentativenesstestingtheutilityoftheglobaldrugsurvey
AT winstockadamr movingonfromrepresentativenesstestingtheutilityoftheglobaldrugsurvey